Pages that link to "Q72649525"
Jump to navigation
Jump to search
The following pages link to Comparison of CHOP chemotherapy with autologous bone marrow transplantation for slowly responding patients with aggressive non-Hodgkin's lymphoma (Q72649525):
Displaying 50 items.
- High-dose chemotherapy with autologous stem cell transplantation in the first line treatment of aggressive Non-Hodgkin Lymphoma (NHL) in adults (Q24242089) (← links)
- Outcomes of patients who participate in randomized controlled trials compared to similar patients receiving similar interventions who do not participate (Q24242288) (← links)
- High-dose chemotherapy with autologous stem cell support for first-line treatment of aggressive non-Hodgkin lymphoma: a systematic review and meta-analysis based on individual patient data (Q24242447) (← links)
- Outcomes of patients who participate in randomised controlled trials compared to similar patients receiving similar interventions who do not participate (Q24245601) (← links)
- Consolidative autologous hematopoietic stem-cell transplantation in first remission for non-Hodgkin lymphoma: current indications and future perspective (Q26998446) (← links)
- International Consensus Conference on high-dose therapy with hematopoietic stem-cell transplantation in aggressive non-Hodgkin's lymphomas: report of the jury. (Q33541091) (← links)
- Standard chemotherapy is superior to high-dose chemotherapy with autologous stem cell transplantation on overall survival as the first-line therapy for patients with aggressive non-Hodgkin lymphoma: a meta-analysis (Q33550417) (← links)
- A prospective study of risk-adapted therapy for large cell non-Hodgkin's lymphoma with VACOP-B followed by high-dose CBV and autologous progenitor cell transplantation for high-risk patients in remission (Q33587594) (← links)
- Autologous hematopoietic cell transplantation in non-Hodgkin's lymphoma (Q33769671) (← links)
- High-Dose Chemotherapy and Radiotherapy With Bone Marrow Transplantation in the Management of the Non-Hodgkin's Lymphomas (Q33862664) (← links)
- Conditioning with treosulfan and fludarabine for patients with refractory or relapsed non-Hodgkin lymphoma (Q33933025) (← links)
- The management of adult aggressive non-Hodgkin's lymphomas (Q33947865) (← links)
- Overview of autologous stem cell transplantation. (Q34038567) (← links)
- Upfront transplantation for poor-risk aggressive non-Hodgkin lymphoma and Hodgkin's disease: who benefits? (Q34214895) (← links)
- The role of cytotoxic therapy with hematopoietic stem cell transplantation in the therapy of diffuse large cell B-cell non-Hodgkin's lymphoma: an evidence-based review (Q34314453) (← links)
- Early failure of frontline rituximab-containing chemo-immunotherapy in diffuse large B cell lymphoma does not predict futility of autologous hematopoietic cell transplantation (Q34325329) (← links)
- Outcomes for patients with the same disease treated inside and outside of randomized trials: a systematic review and meta-analysis. (Q34435947) (← links)
- Treatment of aggressive non-Hodgkin's lymphoma with chemotherapy in combination with filgrastim (Q35024461) (← links)
- Current trends in large cell lymphoma (Q35545076) (← links)
- Autologous stem cell transplantation beyond 60 years of age. (Q36623644) (← links)
- High dose chemotherapy with autologous stem cell transplantation in diffuse large B-cell lymphoma. (Q37244089) (← links)
- Autologous transplantation as consolidation for aggressive non-Hodgkin's lymphoma (Q37700942) (← links)
- Allogeneic stem cell transplantation for patients with relapsed chemorefractory aggressive non-hodgkin lymphomas (Q38267567) (← links)
- Alternating triple therapy for the treatment of intermediate grade and immunoblastic lymphoma (Q38528939) (← links)
- The Use of Conventional Salvage Chemotherapy Before Dose-Intensive Cytotoxic Therapy and Autologous Transplantation for Aggressive-Histology Lymphoma: A Case for Re-Evaluation (Q39227511) (← links)
- The role of autologous stem cell transplantation in the treatment of diffuse large B-cell lymphoma (Q40795258) (← links)
- Clinical Trial: Hematopoietic Progenitor Cell Transplantation in Breast Cancer: Current Status and Future Directions (Q40865994) (← links)
- Autologous bone marrow and peripheral blood stem cell transplantation in haematological malignancies: current status (Q41131752) (← links)
- Management of the histologically aggressive non-Hodgkin's lymphomas in adults (Q41460821) (← links)
- Treatment of aggressive non-Hodgkin's lymphoma in adults--are we doing any better? (Q41471534) (← links)
- Current guidelines for the management of aggressive non-Hodgkin's lymphoma (Q41494475) (← links)
- Autologous Stem Cell Transplantation in Aggressive Non-Hodgkin’s Lymphoma (Q41597859) (← links)
- Favorable Event Free-Survival of High-Dose Chemotherapy Followed by Autologous Hematopoietic Stem Cell Transplantation for Higher Risk Diffuse Large B-Cell Lymphoma in First Complete Remission (Q41907950) (← links)
- Immunophenotype and intermediate-high international prognostic index score are prognostic factors for therapy in diffuse large B-cell lymphoma patients (Q42926639) (← links)
- A randomized controlled trial investigating the survival benefit of dose-intensified multidrug combination chemotherapy (LSG9) for intermediate- or high-grade non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9002. (Q44048667) (← links)
- BEAC or BEAM for high-dose therapy in patients with non-Hodgkin's lymphoma? A single centre analysis on toxicity and efficacy (Q44548374) (← links)
- Early prediction of response to therapy: the clinical implications in Hodgkin's and non-Hodgkin's lymphoma (Q46666583) (← links)
- Primary leptomeningeal histiocytic lymphoma in a young child (Q48857483) (← links)
- Midtreatment 18F-fluorodeoxyglucose positron-emission tomography in aggressive non-Hodgkin lymphoma (Q51646044) (← links)
- Autologous stem cell transplantation in elderly (>60 years) patients with non-Hodgkin's lymphoma: a nation-wide analysis. (Q51823817) (← links)
- Clinical outcome after autologous transplantation in non-Hodgkin's lymphoma patients with high international prognostic index (IPI). (Q53345299) (← links)
- For which patients with aggressive non-Hodgkin's lymphoma is prophylaxis for central nervous system disease mandatory? Dutch HOVON Group. (Q53355180) (← links)
- Intensive brief chemotherapy with hematopoietic growth factors as hematological support and adjuvant radiotherapy improve the prognosis in aggressive malignant lymphoma (Q71244326) (← links)
- Non-Hodgkin's lymphoma (Q71779941) (← links)
- [Role of high-dose chemotherapy in hematology and internal medicine/ oncology] (Q73015234) (← links)
- Feasibility and toxicity of high-dose chemotherapy supported by peripheral blood stem cell transplantation in elderly patients (>/=60 years) with non-Hodgkin's lymphoma: comparison with patients <60 years treated within the same protocol (Q73104290) (← links)
- Costs of peripheral blood progenitor cell transplantation using whole blood mobilised by filgrastim as compared with autologous bone marrow transplantation in non-Hodgkin's lymphoma (Q73121720) (← links)
- [Oncology '96] (Q73315349) (← links)
- Role of high-dose therapy and initial response in survival of poor-risk patients with aggressive non-Hodgkin's lymphoma: a retrospective series on 126 patients from a single center (Q73399810) (← links)
- Autologous stem cell transplantation for clinically aggressive non-Hodgkin's lymphoma: the role of preparative regimens (Q73786509) (← links)